You are here: Industry Insights > MIS-C

News List

COVID Can Affect Brains of Hospitalized Kids drugs.com
January 24, 2022
The coronavirus can leave more than 40% of children hospitalized for COVID-19 with headaches and other lingering neurological symptoms, a new study claims.
Severe COVID in Kids: Rare, but Brain Issues Can Result drugs
July 21, 2021
About one in 20 kids hospitalized with COVID-19 develop debilitating brain or nerve complications that could haunt some for a long time, a new British study reports.
Study shows corticosteroids may be effective in treating COVID-19 complications in children expresspharma
June 21, 2021
The researchers investigated two initial treatments for this condition: a type of steroid called corticosteroids, such as methylprednisolone, and antibody treatment called immunoglobulin.
Children with severe MIS-C do better when treated initially with combined IVIG and steroids firstwordpharma
June 17, 2021
When children started getting sick with a multisystem inflammatory syndrome (MIS-C) in the wake of COVID-19, physicians most often turned to two treatments: IV immunoglobulin (IVIG), because of MIS-C's similarities with Kawasaki disease, and steroids.
Antibody response may drive COVID-19 outcomes worldpharmanews
February 22, 2021
COVID-19, the source of the current pandemic, may be caused by a single virus, but it has a variety of presentations that make treatment difficult. Children, for example, almost exclusively experience mild or asymptomatic COVID-19, while adults can ...
Beckman Coulter Receives Funding to Validate Monocyte Distribution Width in MIS-C Detection americanpharmaceuticalreview
October 22, 2020
Beckman Coulter has been awarded funding by the Biomedical Advanced Research and Development Authority (BARDA) part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services ...
Beckman Coulter receives BARDA funding to validate Monocyte Distribution Width in the rapid detection of Multisystem Inflammatory Syndrome (MIS-C), a severe COVID-19 complication in Children prnewswire
October 16, 2020
Beckman Coulter, a global clinical diagnostics leader, today announced that it was awarded funding by the Biomedical Advanced Research and Development Authority (BARDA) part of the office of the Assistant Secretary for Preparedness and Response at ...
Health Highlights: Sept. 10, 2020 drugs.com
September 24, 2020
There have been 792 confirmed cases in the United States of a rare condition in children that's linked to COVID-19, the U.S. Centers for Disease Control and Prevention said Wednesday.
CDC: Nearly 800 U.S. Children Have Developed COVID-19-Related Condition drugs.com
September 24, 2020
There have been 792 confirmed cases in the United States of a rare condition in children that is linked to COVID-19, the U.S. Centers for Disease Control and Prevention said Wednesday.
FDA Approves Study to Investigate Cell Therapy to Treat COVID-19 Related MIS-C americanpharmaceuticalreview
September 23, 2020
The Cura Foundation in collaboration with The Marcus Foundation, Sanford Health and Alliance for Cell Therapy Now, is supporting a clinical trial of human cord tissue mesenchymal stromal cells (hCT-MSC) to treat children with ...

Previous page 1 2 Next page